Moreover, we observed that expression of cyclin D1, a critical regulator of G1 phase progression of breast cancer cells was found to be significantly downregulated in Smurf2 siRNA treated cells (Figure 10). This evidence concerns the gene SMURF2 and breast carcinoma.